00000nam 2200000zi 4500 9.932127 CaOODSP 20240311120532 m o d f cr mn||||||||| 240105e201703##oncad ob f|0| 0 eng d CaOODSP eng rda CaOODSP n-cn--- H14-493/2017E-PDF Evaluation of the Canadian Agency for drugs and technologies in health activities 2012-2013 to 2015-2016 / prepared by Office of Audit and Evaluation, Health Canada and the Public Health Agency of Canada. [Ottawa] : Health Canada and the Public Health Agency of Canada = Santé Canada et l'Agence de la santé publique du Canada, March 2017. 1 online resource (v, 54 pages) : illustrations, graphs text txt rdacontent computer c rdamedia online resource cr rdacarrier Cover title. Issued also in French under title: Évaluation des activités de l’Agence canadienne des médicaments et des technologies de la santé de 2012-2013 à 2015-2016. Includes bibliographical references (pages 52-54). "This evaluation covered the activities of the Canadian Agency for Drugs and Technologies in Health (CADTH) for the period from 2012-2013 to 2015-2016. The evaluation was undertaken in fulfillment of the requirements of the Financial Administration Act and the Treasury Board of Canada’s Policy on Results (2016) ... The purpose of the evaluation was to assess the relevance and performance of CADTH’s activities. The scope of the evaluation covered various CADTH activities from April 2012 to March 2016, including health technology assessments (HTAs), optimal use projects and common drug reviews (CDR). Where warranted, data outside this timeframe was included in the evaluation"--Executive summary, page ii. Canadian Agency for Drugs and Technologies in Health Evaluation. Canada. Health Canada. Office of Audit and Evaluation, issuing body. Public Health Agency of Canada. Office of Audit and Evaluation, issuing body. Évaluation des activités de l’Agence canadienne des médicaments et des technologies de la santé de 2012-2013 à 2015-2016 / (CaOODSP)9.935144 PDF 701 KB https://publications.gc.ca/collections/collection_2024/sc-hc/H14-493-2017-eng.pdf HTML N/A https://www.canada.ca/en/health-canada/corporate/transparency/corporate-management-reporting/evaluation/2012-2013-2015-2016-canadian-agency-drugs-technologies.html